Recap: Enanta Pharma Q1 Earnings
Recap: Enanta Pharma Q1 Earnings
Enanta Pharma (NASDAQ:ENTA) reported its Q1 earnings results on Wednesday, February 7, 2024 at 04:01 PM.
Enanta Pharma（纳斯达克股票代码：ENTA）于2024年2月7日星期三下午4点01分公布了其第一季度财报。
Here's what investors need to know about the announcement.
以下是投资者需要了解的有关该公告的信息。
Earnings
收益
Enanta Pharma missed estimated earnings by 32.77%, reporting an EPS of $-1.58 versus an estimate of $-1.19.
Enanta Pharma报告每股收益为-1.58美元，未达到预期收益32.77％，而预期为-1.19美元。
Revenue was down $5.58 million from the same period last year.
收入比去年同期下降了558万美元。
Past Earnings Performance
过去的收益表现
Last quarter the company beat on EPS by $0.67 which was followed by a 11.52% increase in the share price the next day.
上个季度，该公司的每股收益高出0.67美元，随后第二天股价上涨了11.52％。
Here's a look at Enanta Pharma's past performance:
以下是Enanta Pharma过去的表现：
| Quarter | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|
| EPS Estimate | -2 | -2.33 | -1.98 | -1.59 |
| EPS Actual | -1.33 | -1.86 | -1.79 | -1.39 |
| Revenue Estimate | 17.50M | 18.06M | 19.18M | 22.57M |
| Revenue Actual | 18.93M | 18.89M | 17.80M | 23.59M |
| 季度 | 2023 年第四季度 | 2023 年第三季度 | 2023 年第二季度 | 2023年第一季度 |
|---|---|---|---|---|
| 每股收益估算 | -2 | -2.33 | -1.98 | -1.59 |
| 实际每股收益 | -1.33 | -1.86 | -1.79 | -1.39 |
| 收入估算 | 17.50 米 | 18.06 米 | 19.18 米 | 22.57 米 |
| 实际收入 | 18.93 亿 | 18.89 米 | 17.80 米 | 23.59 米 |
To track all earnings releases for Enanta Pharma visit their earnings calendar here.
要追踪Enanta Pharma发布的所有财报，请在此处访问其财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。